Benzinga.com

2NLSP : What's Going On With NLS Pharmaceutics Shares Monday?

The equity financing agreements are intended to support the merger between NLS and Kadimastem. NLS also signed a $25 million committed equity facility agreement. Get ahead of next week’s CPI & PPI ...
Yahoo Finance

Exploring Zhejiang Hisun Pharmaceutical And 2 Other Promising Small Caps With Solid Foundations

Overview: Zhejiang Hisun Pharmaceutical Co., Ltd. is involved in the research, development, production, and sale of biological and generic drugs in China, with a market capitalization of CN¥11.31 ...
Nasdaq

NLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2

NLS Pharmaceutics (NLSP) provided insights into the preclinical program evaluating its dual orexin receptor agonist platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed ...
Seeking Alpha

NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform

ZÜRICH, Switzerland, Feb. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLSP) (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), in collaboration with Aexon ...
Nasdaq

NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2

ZURICH, SWITZERLAND / ACCESSWIRE / March 27, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...